Edit Entry | Edit CV

Lucas A Salas, MD, MPH, PhD

Title(s)
Assistant Professor of Epidemiology

Additional Titles/Positions/Affiliations
Investigator Cancer Population Sciences Research Program, Dartmouth Hitchcock- Norris Cotton Cancer Center

Department(s)
Epidemiology

Education
Universitat Pompeu Fabra, PhD 2015
Universitat Pompeu Fabra, MPH 2011
Universidad de Antioquia, Epidemiology 2007
Universidad Nacional de Colombia, MD 2001

Programs
Quantitative Biomedical Sciences
Other

NIH Biosketch
Salas_L_BIO_2020-09-21.pdf

Websites
https://sites.dartmouth.edu/salaslab/
https://orcid.org/0000-0002-2279-4097
https://scholar.google.com/citations?user=FsRf5lQAAAAJ&hl=en
https://publons.com/researcher/1222796/lucas-a-salas/
https://bioconductor.org/packages/release/data/experiment/html/FlowSorted.Blood.EPIC.html
https://bioconductor.org/packages/release/data/experiment/html/FlowSorted.CordBloodCombined.450k.html

Academic Analytics
View Profile

Contact Information


Professional Interests

The broad goal of Dr. Salas research is to investigate how cell heterogeneity impacts human health and disease, with an emphasis on how genetic, environmental, and lifestyle factors model the human epigenome and therefore the cell plasticity. Dr. Salas’ laboratory studies how some key epigenetic mechanisms (DNA methylation, DNA hydroxymethylation, and miRNA alterations) affect gene expression and cancer outcomes, including how the immune cells are altered in this disease. Other research interests include biomarker development, chronic inflammation, and human disease, and how exposures during fetal life alter newborn and childhood outcomes.

Grant Information

W81XWH-20-1-0778, Congressionally Directed Medical Research Programs/Department of Defense
Salas Diaz, Lucas A (PI) 09/01/20-08/31/24
Epigenetic modifications of cytosines in clear cell kidney carcinogenesis and survival
P20 GM104416-09/8299, National Institute of General Medical Sciences
Salas Diaz, Lucas A (PI) 10/01/20-01/01/23
A single-cell approach to disentangle tumor microenvironments in short and long survivors to clear cell renal carcinoma

Courses Taught

QBS.132
CANB.103
MDED.118
QBS.271
PEMM.212

Mentoring Information

Current trainees:
Ze Zhang, QBS
Steven Pike, IND
Prasoona Karra, Ph.D. (postdoctoral fellow)
Chinaza Nnam, MCB (rotation student)


Selected Publications

 

An initial game-theoretic assessment of enhanced tissue preparation and imaging protocols for improved deep learning inference of spatial transcriptomics from tissue morphology.
Fatemi MY, Lu Y, Diallo AB, Srinivasan G, Azher ZL, Christensen BC, Salas LA, Tsongalis GJ, Palisoul SM, Perreard L, Kolling FW 4th, Vaickus LJ, Levy JJ
Brief Bioinform. 2024 Sep 23;25(6) doi: 10.1093/bib/bbae476.
PMID: 39367648

An assessment of compositional methods for the analysis of DNA methylation-based deconvolution estimates.
Alsup A, Nissen E, Salas LA, Molinaro AM, Reiner A, Liu S, Madsen TE, Liu L, Auer PL, Christensen BC, Wiencke JK, Kelsey KT, Koestler DC
Epigenomics. 2024;16(15-16):1067-1080. doi: 10.1080/17501911.2024.2379242. Epub 2024 Aug 2.
PMID: 39093129

Recalibrate concepts of epigenetic aging clocks in human health.
Zhang Z, Christensen BC, Salas LA
Aging (Albany NY). 2024 Jul 17;16(14):11125-11127. doi: 10.18632/aging.206027. Epub 2024 Jul 17.
PMID: 39028368

Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors.
Lee MK, Zhang Z, Sehgal K, Butler R, Stolrow H, Ramush G, Shirai K, Koestler DC, Salas LA, Wiencke JK, Haddad R, Kelsey KT, Christensen BC
Epigenomics. 2024;16(11-12):799-807. doi: 10.1080/17501911.2024.2343274. Epub 2024 May 17.
PMID: 38869472

Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms.
Davidson NR, Barnard ME, Hippen AA, Campbell A, Johnson CE, Way GP, Dalley BK, Berchuck A, Salas LA, Peres LC, Marks JR, Schildkraut JM, Greene CS, Doherty JA
Cancer Epidemiol Biomarkers Prev. 2024 Aug 1;33(8):1114-1125. doi: 10.1158/1055-9965.EPI-24-0113.
PMID: 38780898

Associations in cell type-specific hydroxymethylation and transcriptional alterations of pediatric central nervous system tumors.
Lee MK, Azizgolshani N, Zhang Z, Perreard L, Kolling FW, Nguyen LN, Zanazzi GJ, Salas LA, Christensen BC
Nat Commun. 2024 Apr 30;15(1):3635. doi: 10.1038/s41467-024-47943-9. Epub 2024 Apr 30.
PMID: 38688903

Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cells.
Wiencke JK, Nissen E, Koestler DC, Tamaki SJ, Tamaki CM, Hansen HM, Warrier G, Hadad S, McCoy L, Rice T, Clarke J, Taylor JW, Salas LA, Christensen BC, Kelsey KT, Butler R, Molinaro AM
Res Sq. 2023 Dec 28; pii: rs.3.rs-3793353. doi: 10.21203/rs.3.rs-3793353/v1. Epub 2023 Dec 28.
PMID: 38234734

Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.
Chen JQ, Salas LA, Wiencke JK, Koestler DC, Molinaro AM, Andrew AS, Seigne JD, Karagas MR, Kelsey KT, Christensen BC
Epigenomics. 2024 Jan;16(1):41-56. doi: 10.2217/epi-2023-0358. Epub 2024 Jan 15.
PMID: 38221889

Immunological shifts during early-stage Parkinson's disease identified with DNA methylation data on longitudinally collected blood samples.
Pike SC, Havrda M, Gilli F, Zhang Z, Salas LA
NPJ Parkinsons Dis. 2024 Jan 11;10(1):21. doi: 10.1038/s41531-023-00626-6. Epub 2024 Jan 11.
PMID: 38212355

Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer.
Reynolds SR, Zhang Z, Salas LA, Christensen BC
Clin Epigenetics. 2024 Jan 3;16(1):5. doi: 10.1186/s13148-023-01609-3. Epub 2024 Jan 3.
PMID: 38173042

View more publications on PubMed